Top 10 Pharma Firms

Life Sciences Tools & DiagnosticsBiotechnology / Pharmaceuticals

Source: Alex Philippidis, Genetic Engineering and Biotechnology News (8/21/12)

"Companies earned a spot in the top 10 based on market cap at the end of Q2/12 and Q2/11."

Below are the top 10 pharmaceutical companies based on market capitalization at the end of Q2/12, and the year-ago quarter, calculated by multiplying the number of outstanding shares by the share price. U.S. companies generally report their numbers of outstanding shares in their 10-Q quarterly earnings filings with the Securities & Exchange Commission. Companies based outside the U.S. either disclose market cap directly, or their numbers of shares "in issue" or "in free issue" in half-year and full-year results disclosures.

For all companies, closing share prices as of the dates of their outstanding-shares figures can be found through any of several free stock information websites. Figures of non-U.S. companies were converted from various currencies.

gentop10.1 gentop10.2

Notes:
¹Converted from euros to USD as of Aug. 15; market cap for 2011 reported by company.
²Converted from GBP to USD as of Aug. 15.
³Reported by company to tenths only.
⁴Converted from CHF to USD as of Aug 15.

Alex Philippidis, Genetic Engineering and Biotechnology News

Biotech Discovers Revolutionary Immunotherapy in Houston
Source: Jason Kolbert (04/24/2025)

Coya Therapeutics Inc. (COYA:NASDAQ) recently reported a statistically significant Treg improvement in FTD patients with its dual-action immunotherapy, showing promising neuroprotection, according to a D. Boral research note.

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs
Source: Streetwise Reports (04/24/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company.

Analyst Reveals Undervalued Pharmaceutical Gem in Canada
Source: Dr. Douglas Loe (04/14/2025)

In a recent research note from Leede Financial Inc. analyst Dr. Douglas Loe said Theratechnologies Inc. (TH:TSX; THTX:NASDAQ) has long term potential.

Four-Year Data on New Drug for Early AD Positive
Source: Dr. Ram Selvaraju (04/09/2025)

Long-term treatment with this small molecule seems feasible given its safety and tolerability profile, noted an H.C. Wainwright & Co. report.

Rest of 2025 Rich With Catalysts for Immunotherapy Co.
Source: Jason Kolbert (04/09/2025)

These anticipated events will advance the oncology firm's lead candidate, for lung-only metastatic osteosarcoma, toward commercialization, noted a D. Boral Capital report.